Application of Existing and Emerging Biomarkers for Immuno-Oncology Across Tumor Types

Learn from the experts about current and emerging immuno-oncology biomarkers to guide selection of optimal cancer treatment across tumor types. Participate in the interactive CCO Webinar or watch the on-demand Webcast and download the slides. Listen to a podcast for answers to FAQs asked during the live Webinar.
John L. Marshall, MD
Program Director
Jamie E. Chaft, MD
Scot Niglio, MD

On-Demand Webcast

Watch this on-demand Webcast capturing a live CCO Webinar featuring expert presentations on current and emerging immuno-oncology biomarkers to guide selection of optimal cancer treatment across tumor types.

John L. Marshall, MD
Program Director
Jamie E. Chaft, MD Scot Niglio, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 24, 2020 Expired: August 23, 2021
Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue